Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Palatin Technologies Inc (PTN) (Q3 2024) Earnings Call Transcript Highlights: Navigating ...
Q3 2024 Palatin Technologies Inc Earnings Call
Earnings Call Summary | Palatin Technologies(PTN.US) Q3 2024 Earnings Conference
The following is a summary of the Palatin Technologies, Inc. (PTN) Q3 2024 Earnings Call Transcript:Financial Performance:Palatin Technologies reported no product sales in the quarter ended March 31,
Palatin Technologies Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results.
Palatin Technologies Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 GAAP EPS Results.
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
Palatin Technologies Q3 24 Earnings Conference Call At 11:00 AM ET
Palatin Technologies | 10-Q: Quarterly report
Express News | As Of March 31, 2024, Palatin's Cash, Cash Equivalents And Marketable Securities Were $10M Expected To Provide Cash Runway Into Second Half Of Calendar Year 2024
Palatin Technologies: Runway To Fund Currently Anticipated Operating Expenses, Disbursements Into 2nd Half of CY24 >PTN
Palatin Technologies: Runway To Fund Currently Anticipated Operating Expenses, Disbursements Into 2nd Half of CY24 >PTN
Express News | Palatin Technologies Inc - Qtrly Shr Loss $0.53
Express News | Palatin Technologies- Sees Existing Cash, Cash Equivalents, Marketable Securities, to Be Sufficient to Fund Currently Seen Oper Expenses Into H2 2024
Express News | Palatin Techs Q3 2024 GAAP EPS $(0.53) Misses $(0.50) Estimate
Express News | Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Palatin Technologies 3Q Loss/Shr 53c >PTN
Palatin Technologies 3Q Loss/Shr 53c >PTN
Palatin Technologies Price Target Maintained With a $17.00/Share by HC Wainwright & Co.
Palatin Technologies Price Target Maintained With a $17.00/Share by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)
Palatin Spikes as FDA Clears Mid-stage Trial for Weight Loss Therapy
Express News | HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target